Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT04824092

A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL)

Status

Open

Conditions

Other

Phases

III

Age Group

Adult

Main Investiagtor

Hammond, William

Practice

Lymphoma

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT04824092

Secondary Trial ID Number

MOR208C310

Keywords

Treatment